drugset
drugset / Trial / NCT04140591

Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis

NCT04140591 ↗

Phase 2/3 Terminated 10 enrolled Taipei Veterans General Hospital, Taiwan
RandomizedParallel-groupSingle-blindTreatment

Summary

Proton pump inhibitor plus propranolol versus proton pump inhibitor alone on peptic ulcer healing in patients with liver cirrhosis: a randomized trail

Timeline

Start
2016-12-26
Primary completion
2019-10-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 10 mg —
Comparator Pariet EC Unknown 20 mg —

Indications

cirrhosis of liver peptic ulcer disease